Amundi’s Celestica CLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$117M Buy
319,304
+105,752
+50% +$39.7M 0.03% 424
2026
Q1
$60.2M Buy
213,552
+23,318
+12% +$6.77M 0.02% 560
2025
Q4
$56.2M Sell
190,234
-38,860
-17% -$11.7M 0.02% 612
2025
Q3
$53.9M Sell
229,094
-75,941
-25% -$15.3M 0.02% 543
2025
Q2
$47.2M Buy
305,035
+253,956
+497% +$27M 0.02% 569
2025
Q1
$3.53M Buy
51,079
+51,051
+182,325% +$5.42M ﹤0.01% 1033
2024
Q4
$2.87K Buy
+28
New +$2.19K ﹤0.01% 1966

Other funds holding CLS

Amundi's CLS Position: Q2 2026 in Review

Amundi increased its Celestica (CLS) stake by 50% in Q2 2026, buying an estimated $39.7M and bringing the position to 319,304 shares worth $117M. The position accounts for 0.03% of the portfolio, ranked #424.

Amundi first reported a position in CLS in Q4 2024 and has held it in 7 quarters since. 873 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

  • Amundi held 319,304 shares of Celestica worth $117M as of Q2 2026.
  • Amundi bought 105,752 Celestica shares in Q2 2026, an estimated $39.7M.
  • Celestica made up 0.03% of Amundi's portfolio in Q2 2026, its #424 holding.
  • Amundi first reported a position in Celestica in Q4 2024 and has held it in 7 quarters since.
  • 873 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.